Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Retained Earnings (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Retained Earnings for 15 consecutive years, with $467.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings rose 3512.62% to $467.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $467.5 million, a 3512.62% increase, with the full-year FY2024 number at -$22.7 million, down 65.53% from a year prior.
  • Retained Earnings was $467.5 million for Q3 2025 at Usana Health Sciences, up from -$19.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $467.5 million in Q3 2025 to a low of -$22.8 million in Q1 2025.
  • A 5-year average of $95.4 million and a median of -$10.2 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: tumbled 2891.92% in 2022, then skyrocketed 4618.94% in 2023.
  • Usana Health Sciences' Retained Earnings stood at -$1.5 million in 2021, then tumbled by 768.09% to -$12.8 million in 2022, then fell by 7.1% to -$13.7 million in 2023, then tumbled by 65.53% to -$22.7 million in 2024, then skyrocketed by 2162.17% to $467.5 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Retained Earnings are $467.5 million (Q3 2025), -$19.3 million (Q2 2025), and -$22.8 million (Q1 2025).